SMO ClinPlus CO.,LTD. (SHE:301257)
China
· Delayed Price · Currency is CNY 62.15
-1.87 (-2.92%)
At close: Mar 9, 2026
SMO ClinPlus CO.,LTD. Market Cap
SMO ClinPlus CO.,LTD. has a market cap or net worth of 4.91 billion as of March 9, 2026. Its market cap has increased by 121.99% in one year.
Market Cap
4.91B
Enterprise Value
4.27B
Revenue
819.09M
Ranking
n/a
PE Ratio
45.08
Stock Price
62.15
Market Cap Chart
Since May 17, 2022, SMO ClinPlus CO.,LTD.'s market cap has increased from 4.48B to 4.91B, an increase of 9.64%. That is a compound annual growth rate of 2.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 5.06B | 23.02% |
| Dec 31, 2025 | 4.11B | 91.80% |
| Dec 31, 2024 | 2.14B | -44.81% |
| Dec 29, 2023 | 3.88B | 32.91% |
| Dec 30, 2022 | 2.92B | -34.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Thalys Medical Technology Group | 4.78B |
| Shanghai Labway Clinical Laboratory | 4.22B |
| Berry Genomics Co.,Ltd | 4.18B |
| Guangdong Hybribio Biotech | 4.14B |
| Medicalsystem Biotechnology | 3.92B |
| Cowealth Medical China | 6.80B |
| Maccura Biotechnology Co.Ltd | 6.95B |
| Beijing Strong Biotechnologies,Inc. | 7.36B |